Skip to main content
Anupam Rasayan India Limited logo

Anupam Rasayan India Limited — Investor Relations & Filings

Ticker · ANURAS ISIN · INE930P01018 LEI · 3358004GQZY8E2J1SV40 BSE.NS Manufacturing
Open in API
Filings indexed 557 across all filing types
Latest filing 2026-05-25 Report Publication Anno…
Country IN India
Listing BSE.NS ANURAS

About Anupam Rasayan India Limited

https://www.anupamrasayan.com/

Anupam Rasayan India Limited specializes in the custom synthesis and manufacturing (CSM) of specialty chemicals. The company operates primarily in two business verticals: life science-related specialty chemicals and other specialty chemicals. Its product portfolio includes high-value intermediates for agrochemicals, personal care, and pharmaceuticals, as well as specialty pigments, dyes, and polymer additives. The firm is recognized for its expertise in complex multi-step synthesis and diverse chemistries, such as fluorination, hydrogenation, and nitration. Anupam Rasayan serves a global clientele, including several multinational corporations across Europe, Japan, and the United States. With a strong focus on research and development, it maintains advanced manufacturing facilities and provides end-to-end solutions from process development to commercial-scale production, ensuring high quality and sustainability standards.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Report Publication Announcement Classification · 85% confidence The document is a brief notice to stock exchanges informing that the audio recording of the earnings call on the audited financial results for Q4 and FY ended March 31, 2026, is now available on the company’s website. It does not contain the earnings data or transcript itself, but simply announces the publication of a report (audio recording). This fits the definition of a Report Publication Announcement (RPA).
2026-05-25 English
Submission of Audio Recording of the Earnings Call on the Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31, 2026.
Report Publication Announcement Classification · 87% confidence The document is a short notification to stock exchanges that the audio recording of the company’s earnings call on the audited financial results is now available on the company website. It contains no substantive financial data or actual report content, only an announcement that the recording is published. Per the classification definitions, this is a Report Publication Announcement (RPA).
2026-05-25 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 85% confidence The document is a formal submission to India’s stock exchanges of newspaper advertisement clippings for the Audited Financial Results (quarter and year ended March 31, 2026). It does not include the full financial statements—only highlights—and its purpose is to notify the exchange (in compliance with SEBI Regulation 47) that the Financial Results have been published (in newspapers and online). This matches an announcement of report publication rather than the report itself, so it should be classified as Report Publication Announcement (RPA).
2026-05-25 English
Newspaper Publication regarding Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended March 31, 2026.
Report Publication Announcement Classification · 72% confidence The text is a letter filed with the stock exchanges under SEBI LODR Regulation 47 submitting newspaper advertisement clippings of the Company’s Audited Financial Results and informing that the results have been published and hosted on its website. It does not itself constitute the full Annual or Interim Report but merely announces the publication of the financial results in newspapers and on the website. Per the “menu vs meal” rule, this is an announcement of report publication rather than the report itself.
2026-05-25 English
Resignation of Director/KMP/SMP
Regulatory Filings
2026-05-23 English
Investor Presentation regarding Bliss GVS Pharma Limited Acquisition.
Investor Presentation Classification · 92% confidence The document is an official notification to stock exchanges (BSE and NSE) under SEBI LODR Regulation 30, enclosing an ‘Investor Presentation’ regarding the Bliss GVS Pharma acquisition. The content consists of slide decks detailing company overview, transaction details, financials, strategy, and market position. This matches the definition of an Investor Presentation (IP).
2026-05-23 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.